Imaging the brain in dementia: Expensive and futile?

American Journal of Neuroradiology

Volumn 18, Issue 10, 1997, Pages 1847-1850

  George, Ajax E ^a   De Leon, Mony J ^a   Colomb, James ^a   Kluger, Alan ^a   Convit, Antonio ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dementia; Economics; Special reports

Indexed keywords

ALZHEIMER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DEMENTIA; HUMAN; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; BRAIN DAMAGE, CHRONIC; COST-BENEFIT ANALYSIS; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MEDICAL FUTILITY;

EID: 0031545995     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Schoenberg BS. Epidemiology of Alzheimer's disease and other dementing disorders. J Chronic Dis 1986;39:1095-1104
2. Clark RF, Goate AM. Molecular genetics of Alzheimer's disease. Arch Neurol 1993;50:1164-1172
3. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported JAMA 1989;262:2551-2556
4. Larrabee GJ, Crook TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994;6:95-104
5. George AE, de Leon MJ, Stylopoulos LA, et al. CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol 1990;11: 101-107
6. de Leon MJ, Ferris SH, George AE, et al. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Ahheimer's type. Neurobiol Aging 1980;1:60-69
7. Huckman MS, Fox J, Topel J. The validity of criteria for the valuation of cerebral atrophy by computed tomography. Radiology 1975;116:85-92
8. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
9. Wolf AP, Fowler JS. Positron emission tomography: biomedical research and clinical application. Neuroimaging Clin N Am 1995; 5:87-101
10. Newberg AB, Alavi A, Payer F. Single photon emission tomography in Alzheimer's disease and related disorders. Neuroimaging Clin N Am 1995;5:103-123
11. McClure RJ, Kanfer JN, Pachalingam K, et al. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease. Neuroimaging Clin N Am 1995;5:69-86
12. Ernst T, Chang L, Melchor R, et al. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829-836
13. de Leon MJ, Colomb J, George AE, et al. The radiologic prediction of Alzheimer's disease: the hippocampal formation. AJNR Am J Neuroradiol 1993;14:897-906
14. Feinberg DA. Modern concepts of brain motion and cerebrospinal fluid flow. Radiology 1992;185:630-632
15. Golomb J, de Leon MJ, George AE, et al. Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1994;57:590-593
16. George AE, de Leon MJ, Rosenbloom S, et al. Ventricular volume and cognitive deficit: a computed tomographic study. Radiology 1983;149:493-498
17. Rusinek H, de Leon MJ, George AE, et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991;78;109-114
18. Le May M. CT changes in dementing diseases. AJNR Am J Neuroradiol 1986;7:841-853
19. Ball MJ, Hachinski V, Fox A, et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985;1:14-16
20. Hyman BT, Van Hoesen GW, Damasio AR, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170
21. Convit A, de Leon MJ, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997;18:1-9
22. Golomb J, de Leon MJ, Kluger A, et al. Hippocampal atrophy in normal aging: an association with recent memory impairment. Arch Neurol 1993;50:967-976
23. Smith GS, de Leon MJ, George AE, et al. Tomography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Arch Neurol 1992;49:1142-1150
24. Hakim S, Adams RD. The clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure: observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965;2: 307-327
25. Brun A, Englund. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19: 253-262
26. George AE, de Leon MJ, Gentes CL, et al. Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies; and 2. MRI of brain lucencies. AJNRAm J Neuroradiol 1986;7:561-566; 567-570
27. Golomb J, Kluger A, Gianutsos J, et al. Nonspecific white matter lesions associated with aging. Neuroimaging Clin N Am 1995;5: 33-44
28. Kluger A, Gianutsos J, de Leon MJ, et al. The significance of age elated white matter lesions. Stroke 1988;19:1054-1055
29. Masdeu JC, Wolfson L, Lantos G, et al. Brain white matter changes in the elderly prone to falling. Arch Neurol 1989;46: 1292-1296
30. Ebisu T, Tanaka C, Umeda M, et al. Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion-weighted and T2-weighted echo-planar MR imaging. Radiology 1997;203:823-828
31. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995;26:1293-1301